Kriya Therapeutics (Series C)
Funding Details
Awarder
Inbox
Date Award
May 17, 2022
Vertical
Gene Therapy
Funding Amount
$270,000,000
Company Info
Founders
Shankar Ramaswamy
Market
Healthcare
Location
Redwood City, California, USA
Coinvestors
Bluebird Ventures, CAM Capital, Dexcel Pharma, Foresite Capital, JDRF T1D Fund, Lightswitch Capital, Narya, Patient Square Capital, QVT Financial, Transhuman Capital
Company Description

Kriya Therapeutics is a biopharmaceutical company that develops gene therapies for ophthalmology, neurology, and metabolic diseases.